An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma
Clinical trial NCT01368276 · COMPLETED
Trial details
- NCT number
- NCT01368276
- Sponsor
- BioVex Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.